FAK activation: Cells were cultured in growth medium containing with or without recombinant lumican protein (100 ng/mL) for 8 h. The cell lysates were harvested and the protein expression was determined by Western blotting analysis. The expression level of detected proteins in each cell was normalized to internal control (actin) individually and the numbers indicated that the expression level of FAK, pFAK and lumican in cells under different treatment as compared to that in the cells transfected with control vector (VC).
. The expression of integrin  1 and  2 in the surface of bone metastatic LLC/luc cells. The surface expression of integrin  1(left panel) and  2 (right panel) in bone metastatic LLC/luc cells was determined by flow cytometric analysis. Key: ━ : Isotype; --:  1 or  2 specific antibody. Table 2 . Upregulation of genes associated with ECM and EMT in bone metastatic LLC/luc cells. The significant differentially-expressed genes were identified as |log2 (Genes expressed in LLC BM 2nd /Genes expressed in LLC P)|>1, and 269 genes were up-regulated in LLC BM 2 nd cells. We found that lumican displayed the highest fold change of differentially-expressed gene. After analyzing the functional enrichment of differentially-expressed genes by using Database for Annotation, Visualization, and Integrated Discovery (DAVID) online tool, the functional annotation results showed that the genes associated with extracellular matrix, including several EMT associated genes, such as, AEBP1, S100A4, FGF10, LUM, NRP1 and TNC, were the most enriched in our model. Besides those EMT-associated genes, several genes encoding for ECM associated protein were enriched in this model, such as CCL7, COL6A3, DCN, DPT, ECM1, LUM and MGP. 
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